Caligenix

Caligenix is a biotechnology company developing personalized genomic diagnostic kits. The companys mission is to increase understanding of the link between genetic variation and individual dietary response as well as the overall role of nutrients in gene expression. The company is set to enable its B2B clients to further customize and optimize their health and wellness offerings based on genomic data. Through research and technological development, Caligenix undertakes different activities in order to develop and improve new products and services. Caligenix currently offers two tests. Both tests consist of a panel of 45 genetic markers related to several important aspects of the customers lifestyle, including weight management and body composition, nutrient metabolism, eating habits, cardiometabolic health, food intolerances, and physical activity. The Caligenix Health and Wellness test is intended for the general public to optimize health and well-being, and the Sports test is focused on enhancing performance and decreasing injury risk while optimizing health. The simple saliva tests are processed in CLIA-certified and CAP-accredited labs and included in a personalized report. All reports are available online on both desktop and mobile.

Caligenix has raised $720K in total funding across 1 rounds. The company is currently at the Mature stage. Key investors include Undisclosed Investor(s).

Caligenix was founded in 2014 by Dr. Tzur Gabi (Co-founder), Eliad Josephson (Co-founder).

Caligenix operates in Health Tech & Life Sciences, Digital Healthcare, Medical Decision Support, Digital Therapeutics, with core technologies in Biologicals, Genes, Molecules, Artificial Intelligence. Target customers: Healthcare & Life Sciences, Healthcare, Laboratories, Providers.

Caligenix is based in Aluf Kalman Magen St 3, Tel Aviv-Yafo, Israel, Center District. The company also has offices abroad.